id: lack_effective_therapeutic_agents_to_chronic_pancreatitis_pain
name: Lack of Effective Therapeutic Agents for Chronic Pancreatitis â†’ Chronic Pancreatitis
  Pain
from_node:
  node_id: lack_effective_therapeutic_agents
  node_name: Lack of Effective Therapeutic Agents for Chronic Pancreatitis
to_node:
  node_id: chronic_pancreatitis_pain
  node_name: Chronic Pancreatitis Pain
direction: positive
category: healthcare_access
mechanism_pathway:
- 'Step 1: Absence of specifically tailored therapeutic agents for chronic pancreatitis
  limits treatment options available to clinicians'
- 'Step 2: Without effective disease-modifying therapies, underlying inflammatory
  and neural mechanisms of pain remain unaddressed'
- 'Step 3: Patients continue to experience persistent or recurrent pain without adequate
  pharmaceutical interventions'
- 'Step 4: Lack of therapeutic pipeline creates systematic barrier to pain management
  across all patient populations with CP'
evidence:
  quality_rating: C
  n_studies: 1
  primary_citation: 'C. Forsmark et al. 2018. "Accelerating the Drug Delivery Pipeline
    for Acute and Chronic Pancreatitis: Summary of the Working Group on Drug Development
    and Trials in Chronic Pancreatitis at the National Institute of Diabetes and Digestive
    and Kidney Diseases Workshop.." *Pancreas*. https://doi.org/10.1097/MPA.0000000000001174'
last_updated: '2025-12-02'
version: '1.0'
llm_metadata:
  extracted_by: claude-sonnet-4-5-20250929
  extraction_date: '2025-12-02T18:12:07.158064'
  batch_id: msgbatch_01AKnPJgzm7Fk9qubgAz9GaD
